How should a 76-year-old patient with prior neck surgery who is taking gabapentin and tizanidine be managed after presenting with syncope and hypotension?

Immediately Discontinue Tizanidine—It Is the Likely Culprit

Tizanidine should be stopped immediately in this 76-year-old patient presenting with syncope and hypotension, as this alpha-2 adrenergic agonist is well-documented to cause dose-related hypotension, orthostatic hypotension, bradycardia, and syncope. 1

Immediate Management

Discontinue the Offending Agent

• Stop tizanidine immediately—the FDA label explicitly warns that tizanidine causes hypotension in a dose-related manner, with syncope reported as a known adverse effect 1
• In single-dose studies, two-thirds of patients on 8 mg experienced a 20% reduction in systolic or diastolic blood pressure within 1 hour, peaking at 2-3 hours, and this was "associated, at times, with bradycardia, orthostatic hypotension, lightheadedness/dizziness and rarely syncope" 1
• The hypotensive effect occurs with doses as low as 2 mg 1

Evaluate for Orthostatic Hypotension

• Measure blood pressure supine and after standing for 1-3 minutes
• Look for a drop in systolic BP ≥20 mmHg or diastolic BP ≥10 mmHg—this defines orthostatic hypotension per ACC/AHA/HRS guidelines 2
• Patients moving from supine to upright position are at increased risk when on tizanidine 1

Consider Gabapentin's Contribution

• While gabapentin is less commonly associated with hypotension than tizanidine, recent evidence shows it can contribute to postoperative hypotension 3
• However, tizanidine is the primary concern given its well-established mechanism as an alpha-2 agonist causing direct hypotension 1
• Consider reducing or discontinuing gabapentin if hypotension persists after stopping tizanidine

Critical Drug Interaction Considerations

Screen for Concurrent Medications

This elderly patient likely has multiple comorbidities. Check specifically for:

• Antihypertensives (ACE inhibitors, ARBs, beta-blockers): Tizanidine has documented synergistic hypotensive effects with these agents 4, 5
• CYP1A2 inhibitors (ciprofloxacin, fluvoxamine): These dramatically increase tizanidine levels, with ciprofloxacin showing a 28-fold increased risk of hypotension 6
• Alcohol: Increases tizanidine AUC by 20% and Cmax by 15%, with additive CNS depression 1, 7

The FDA label explicitly states: "Caution is advised when tizanidine is to be used in patients receiving concurrent antihypertensive therapy and should not be used with other α2-adrenergic agonists" 1

Syncope Workup Per Guidelines

Following the 2017 ACC/AHA/HRS syncope guidelines 2:

Initial Evaluation Must Include:

• Thorough history focusing on:

  • Timing of syncope relative to medication dosing (tizanidine peaks 2-3 hours post-dose 1)
  • Position when syncope occurred (upright position suggests orthostatic cause 2)
  • Prodromal symptoms (lightheadedness, dizziness—classic for tizanidine 1)

• Physical examination with orthostatic vital signs (as described above)

• ECG to rule out cardiac causes (bradycardia is also a tizanidine adverse effect 1)

Classify the Syncope Type

Based on the clinical picture, this appears to be drug-induced orthostatic hypotension rather than:

• Reflex (vasovagal) syncope
• Cardiac syncope
• Neurogenic orthostatic hypotension

Management of Drug-Induced Orthostatic Hypotension

Acute Phase (While Hospitalized):

1. Discontinue tizanidine (do NOT taper abruptly if on high doses for prolonged periods—risk of rebound hypertension and tachycardia 1)
2. Ensure adequate hydration—IV fluids if needed
3. Monitor blood pressure closely, especially with position changes
4. Hold or reduce other antihypertensives temporarily if present

Non-Pharmacologic Measures (Per ACC/AHA/HRS Guidelines):

If orthostatic hypotension persists after drug discontinuation 2:

• Physical counter-pressure maneuvers: leg crossing, squatting, lower body muscle tensing
• Compression garments: at least thigh-high, preferably including abdomen
• Acute water ingestion: ≥480 mL for temporary relief (peak effect at 30 minutes)
• Increased salt intake: 6-9 g/day (avoid if history of heart failure or renal disease)

Pharmacologic Options (Only if Neurogenic OH Confirmed):

These are NOT indicated for simple drug-induced orthostatic hypotension 2:

• Midodrine
• Droxidopa
• Fludrocortisone

Alternative Spasticity Management

Since this patient was on tizanidine for presumed spasticity from neck surgery:

• Physical therapy and stretching exercises should be the primary approach
• Consider baclofen as an alternative if pharmacotherapy is absolutely necessary, though it also carries hypotension risk
• Avoid restarting tizanidine in elderly patients, especially those on antihypertensives

Key Pitfalls to Avoid

1. Do not restart tizanidine in this patient—the risk-benefit ratio is unfavorable in a 76-year-old who has already experienced syncope
2. Do not miss concurrent CYP1A2 inhibitors—these create dangerous drug interactions 6
3. Do not abruptly stop high-dose tizanidine (>24 mg/day for prolonged periods)—taper to avoid rebound hypertension 1
4. Do not attribute syncope to age alone—drug-induced orthostatic hypotension is a reversible cause 8
5. Do not overlook alcohol use—this potentiates tizanidine's hypotensive effects significantly 7

Monitoring After Discharge

• Recheck orthostatic vital signs at follow-up
• Ensure blood pressure normalizes off tizanidine
• Educate patient about rising slowly from supine/seated positions
• Review all medications for potential hypotensive agents